Monday, June 15, 2026

North Korea Begins Removing Loudspeakers Facing South After Seoul’s Similar Move

South Korea and North Korea dismantle loudspeakers in a move to ease border tensions, with both sides responding swiftly.

Are Your Biotech Stocks Safe? New KOSDAQ Regulations Could Mean Trouble for 21 Companies

KOSDAQ's delisting rules tighten with new market cap thresholds, impacting biotech firms. Stricter criteria may challenge innovation.

Coupang Says Will Provide Responsible Compensation, Not In Violation Of US Laws

Coupang's interim CEO, Harold Rogers, addresses a data breach at a National Assembly hearing, committing to customer compensation and security improvements.

Tag: ophthalmic treatments

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

Top News

- Our Sponsors Ad -

Follow us